Evaluation of favipiravir treatment before intensive care in COVID-19 patients
The purpose of this study is to investigate the healing effect of Favipiravir used in pre-intensive care treatment of patients diagnosed with COVID-19 in order to elucidate the pathogenesis and complications of coronavirus. The data regarding the clinical findings of the patients in the hospital inf...
Guardado en:
Autores principales: | Osman Ozudogru, Emrah Yerlikaya, Naci Omer Alayunt, Zafer Çambay |
---|---|
Formato: | article |
Lenguaje: | ID |
Publicado: |
Poltekkes Kemenkes Yogyakarta
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8164a2292dce445898ae98461d4bb3fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
por: Qomara WF, et al.
Publicado: (2021) -
Favipiravir Inhibits Mayaro Virus Infection in Mice
por: Michèle Bengue, et al.
Publicado: (2021) -
Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
por: Hideki Tani, et al.
Publicado: (2016) -
Supporting Decision Making in Intensive Care: Ethical Principles for Managing Access to Care During the COVID-19 Pandemic
por: Stefano D'Errico, et al.
Publicado: (2021) -
Impact and Perspectives of Pediatric Dental Care during the COVID-19 Pandemic Regarding Unvaccinated Children: A Cross-Sectional Survey
por: Nelly Schulz-Weidner, et al.
Publicado: (2021)